Efficacy and Safety of Formulation Switching Between SC Infliximab and IV Infliximab in Patients With CD
Clinical trial NCT06064864 · RECRUITING
Trial details
- NCT number
- NCT06064864
- Sponsor
- Asan Medical Center
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-09
- Primary completion
- 2026-12-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.